Evidence map›Paper›PMID 34292140›Full record

ArticleHuman vaccines & immunotherapeutics2021

Intention to get vaccinated against COVID-19 among the general population in France: Associated factors and gender disparities.

Caroline Alleaume, Pierre Verger, Fadia Dib, Jeremy K Ward, Odile Launay, Patrick Peretti-Watel

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Between intention and action: the paradoxes of female vaccination.Archives of public health = Archives belges de sante publique · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caroline AlleaumeSoutheastern Health Regional Observatory (ORS Paca), Faculté De Médecine, Marseille Cedex 5, France.ORCID 0000-0002-7090-7025
Pierre VergerSoutheastern Health Regional Observatory (ORS Paca), Faculté De Médecine, Marseille Cedex 5, France.
Fadia DibINSERM CIC 1417, F-CRIN, I REIVAC, Assistance Publique- Hôpitaux De Paris, Hôpital Cochin, Paris Cedex 14, France.
Jeremy K WardIRD, AP-HM, SSA, VITROME, IHU, Aix-Marseille University, Marseille, France.
Odile LaunayInserm, F-crin I Reivac, Toulouse, France.ORCID 0000-0003-3242-7247
Patrick Peretti-WatelSoutheastern Health Regional Observatory (ORS Paca), Faculté De Médecine, Marseille Cedex 5, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the coronavirus disease 2019 (COVID-19) spreads across the world, the rapid distribution of an effective vaccine and its acceptability among the population constitute priorities for health authorities. This study aimed to document attitudes of the general population toward a future vaccine against COVID-19. We used the national COCONEL surveys conducted during the lockdown to identify factors associated with vaccine refusal, in the whole population, and separately among men and women. We investigate the role of socioeconomic and demographic factors as well as exposure to COVID-19. Among the 5,018 participants, 24.0% reported their intention to refuse the vaccine. Thinking this vaccine would not be safe, being against vaccination in general, and perceiving COVID-19 to be harmless were the three main reasons given to explain vaccine refusal. Women were more likely to refuse the vaccine, especially due to a reluctance toward vaccination in general or the perception that a COVID-19 vaccine would not be safe. Some factors associated with the intention to refuse the vaccine were the same among men and women such as a lack of prior vaccination against influenza, and concern over being infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while others differed slightly according to gender such as age, and high prevalence of COVID-19 in their region of residence. Authorities should therefore guarantee that all the necessary precautions are taken before marketing the vaccine and communicate transparently on the process of its development, and on the coverage rate required to reach herd immunity.

Indexed as

COVID-19Influenza VaccinesCommunicable Disease ControlCOVID-19 VaccinesCross-Sectional StudiesFemaleFranceHumansIntentionMaleSARS-CoV-2VaccinationCOVID-19 VaccinesInfluenza VaccinescoconelCOVID-19French populationgender analysisvaccination attitude

Identifiers

PMID34292140
PMCPMC8437523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.